Volume 7 Issue 327
Published - 14:00 UTC 08:00 EST 12-Dec-2005 
Next Update - 14:00 UTC 08:00 EST 13-Dec-2005

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.



Race and gender affect lung cancer clinical trial participation

A new study finds significant disparities by race and gender in the enrollment of patients into lung cancer clinical trials. Published in the January 15, 2006 issue of Cancer, the study indicates that women and African-Americans were least likely to enroll in treatment trials for lung cancer, and identifies a need to improve educational and outreach efforts to make clinical trials available to a wider range of patients. more  

Prostate cancer test affected by demographic and lifestyle factors

The reliability of a prostate cancer-screening test may be compromised by lifestyle and demographic factors, according to a new study. Published in the January 15, 2006 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study reveals the (rate of) change in concentration of prostate specific antigen (PSA) over time--a calculation called PSA velocity--can be significantly affected by age, race, and diet, leading to falsely lower or elevated values and possible misinterpretation by doctors. more

TLR4 gene found to protect against tumor development

A new study finds that a gene which plays an important role in immune function, known as toll-like receptor 4 (TLR4), may also play a critical role in suppressing chronic lung inflammation and tumor development in mice. more  

New video shows clinicians how to treat children exposed to chemicals used in bioterrorist attacks

Today, the Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) released The Decontamination of Children: Preparedness and Response for Hospital Emergency Departments, a 27-minute video that trains emergency responders and hospital emergency department staff to decontaminate children after being exposed to hazardous chemicals during a bioterrorist attack or other disaster. more

Hospital admissions of HIV patients have fallen by more than half since 1995  

The number of hospital admissions for HIV infection in the United States declined from a high of 149,000 in 1995—just before approval of life-prolonging protease inhibitor drugs known as the "AIDS cocktail"—to 70,000 admissions in 2003, according to statistics released by HHS' Agency for Healthcare Research and Quality. During the same period, the percentage of AIDS patients who died in the hospital dropped by 32 percent—from a death rate of 12.5 percent in 1995 to 8.5 percent in 2003. more

Next steps after your diagnosis finding information and support 

Next Steps After Your Diagnosis offers general advice for people with almost any disease or condition. And it has tips to help you learn more about your specific problem and how it can be treated. The information here is presented in a simple way to help you scan the material and read only what you need right now. Organizations, publications, and other resources are included if you would like to know more. This online version has many additional resources with their Internet links. more

FDA advising of risk of birth defects with Paxil; Agency requiring updated product labeling

The Food and Drug Administration alerted health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy. Paxil is approved for the treatment of depression and several other psychiatric disorders. FDA is currently gathering additional data and waiting for the final results of the recent studies in order to better understand the higher risk for birth defects that has been seen with Paxil. more


Studies suggest that Paxil increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy